Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS)

CUSIP: 03753U106

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
127,672,507
Total 13F shares
62,139,394
Share change
+938,554
Total reported value
$1,874,756,231
Put/Call ratio
48%
Price per share
$30.17
Number of holders
143
Value change
+$24,663,304
Number of buys
70
Number of sells
67

Security key

03753U106

Report period

Q3 2020

Institutions

143

Top holders

10

Top shareholders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
8.2%
10,444,511
$341,118,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
4.8%
6,176,808
$201,734,000 30 Jun 2020
13F
HHLR ADVISORS, LTD.
13F
Company
3.9%
5,028,289
$164,224,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
3.4%
4,388,181
$143,318,000 30 Jun 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.4%
3,027,835
$98,889,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
2.3%
2,946,814
$96,243,000 30 Jun 2020
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
1.8%
2,250,000
$73,485,000 30 Jun 2020
13F
JENNISON ASSOCIATES LLC
13F
Company
1.7%
2,127,078
$69,470,000 30 Jun 2020
13F
Cormorant Asset Management, LP
13F
Company
1.6%
2,066,108
$67,479,000 30 Jun 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
1.5%
1,964,545
$64,162,000 30 Jun 2020
13F
CITADEL ADVISORS LLC
13F
Company
1.1%
1,369,760
$44,737,000 30 Jun 2020
13F
S.c.a. Candriam
13F
Individual
0.95%
1,210,398
$39,533,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.84%
1,075,250
$35,118,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.79%
1,013,060
$33,087,000 30 Jun 2020
13F
FIL Ltd
13F
Company
0.77%
979,716
$31,998,000 30 Jun 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.72%
921,200
$30,086,000 30 Jun 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
0.7%
896,551
$29,281,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.68%
865,879
$28,279,000 30 Jun 2020
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.6%
768,609
$25,103,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.55%
697,884
$22,792,000 30 Jun 2020
13F
FIDUCIARY TRUST CO
13F
Company
0.46%
592,591
$19,354,000 30 Jun 2020
13F
Invesco Ltd.
13F
Company
0.45%
572,113
$18,685,000 30 Jun 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.43%
549,538
$17,948,000 30 Jun 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.43%
545,087
$17,803,000 30 Jun 2020
13F
D. E. Shaw & Co., Inc.
13F
Company
0.42%
531,761
$17,367,000 30 Jun 2020
13F
venBio Partners LLC
13F
Company
0.39%
501,584
$16,382,000 30 Jun 2020
13F
FMR LLC
13F
Company
0.39%
498,222
$16,272,000 30 Jun 2020
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.33%
425,791
$13,906,000 30 Jun 2020
13F
Eversept Partners, LP
13F
Company
0.33%
420,932
$13,747,639 30 Jun 2020
13F
CLOUGH CAPITAL PARTNERS L P
13F
Company
0.32%
405,834
$13,255,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.28%
362,289
$11,833,000 30 Jun 2020
13F
BANK OF MONTREAL /CAN/
13F
Company
0.26%
334,830
$10,627,000 30 Jun 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.21%
272,335
$8,894,000 30 Jun 2020
13F
Man Group plc
13F
Company
0.2%
257,346
$8,405,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
0.19%
243,632
$7,957,000 30 Jun 2020
13F
Point72 Asset Management, L.P.
13F
Company
0.16%
208,103
$6,797,000 30 Jun 2020
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.15%
190,000
$6,205,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.14%
178,639
$5,835,000 30 Jun 2020
13F
Tekla Capital Management LLC
13F
Company
0.14%
173,494
$5,666,000 30 Jun 2020
13F
AXA S.A.
13F
Company
0.13%
170,634
$5,573,000 30 Jun 2020
13F
Rhenman & Partners Asset Management AB
13F
Company
0.13%
165,000
$5,389,000 30 Jun 2020
13F
Swiss National Bank
13F
Company
0.11%
134,600
$4,396,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.1%
132,834
$4,338,000 30 Jun 2020
13F
CREDIT SUISSE AG/
13F
Company
0.1%
127,599
$4,168,000 30 Jun 2020
13F
NORGES BANK
13F
Company
0.08%
104,687
$3,419,000 30 Jun 2020
13F
ALPS ADVISORS INC
13F
Company
0.08%
103,013
$3,364,000 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.08%
101,139
$3,304,000 30 Jun 2020
13F
Verition Fund Management LLC
13F
Company
0.08%
99,045
$3,235,000 30 Jun 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.08%
96,300
$3,145,000 30 Jun 2020
13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
13F
Company
0.07%
91,678
$2,994,000 30 Jun 2020
13F

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) as of Q3 2020

As of 30 Sep 2020, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,139,394 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., HILLHOUSE CAPITAL ADVISORS, LTD., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, JENNISON ASSOCIATES LLC, FARALLON CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, and VICTORY CAPITAL MANAGEMENT INC. This page lists 143 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
141
Q3 2020 holders
143
Holder diff
2
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .